標(biāo)題: Titlebook: Gallbladder Cancer; Current Treatment Op Vijay Kumar Shukla,Manoj Pandey,Ruhi Dixit Book 2023 The Editor(s) (if applicable) and The Author( [打印本頁] 作者: ARGOT 時間: 2025-3-21 18:36
書目名稱Gallbladder Cancer影響因子(影響力)
書目名稱Gallbladder Cancer影響因子(影響力)學(xué)科排名
書目名稱Gallbladder Cancer網(wǎng)絡(luò)公開度
書目名稱Gallbladder Cancer網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Gallbladder Cancer被引頻次
書目名稱Gallbladder Cancer被引頻次學(xué)科排名
書目名稱Gallbladder Cancer年度引用
書目名稱Gallbladder Cancer年度引用學(xué)科排名
書目名稱Gallbladder Cancer讀者反饋
書目名稱Gallbladder Cancer讀者反饋學(xué)科排名
作者: 突襲 時間: 2025-3-21 20:56
Planning for War: London and the Localities,allbladder, there is an ongoing debate as to whether such a practice should be performed routinely or on a selective basis. This chapter reviews data addressing both strategies. We also report our personal experience on the subject and conclude by providing an evidence-based approach to examining gallbladder specimens.作者: 加入 時間: 2025-3-22 03:48
Biografie- und agencytheoretischer Zugang,t an early stage, in addition to adjuvant chemotherapy and radiation. In the present chapter, we will discuss the advent of minimally invasive techniques, laparoscopy, and robotics in the hepatobiliary surgery field.作者: 繁重 時間: 2025-3-22 08:35 作者: Defense 時間: 2025-3-22 10:45
Agency and Action in Colonial AfricaThe use of adjuvant therapy has been found to be effective through various clinical trials. In the present chapter, we have discussed the data on adjuvant treatment of GBC and explore therapeutic methods for the patients in the adjuvant setting.作者: Indolent 時間: 2025-3-22 15:52
A Gradualist Metaphysics of Agencyoses a therapeutic as well as a diagnostic challenge. Thick-walled gallbladder can be double-edged sword where morbid procedure could be performed for a benign pathology and vice versa. Following strict protocols and having a stringent clinical judgment may prevent any catastrophe.作者: Indolent 時間: 2025-3-22 21:07 作者: SLING 時間: 2025-3-23 00:36 作者: dapper 時間: 2025-3-23 04:21
Adjuvant Therapy of Gallbladder CancerThe use of adjuvant therapy has been found to be effective through various clinical trials. In the present chapter, we have discussed the data on adjuvant treatment of GBC and explore therapeutic methods for the patients in the adjuvant setting.作者: Intrepid 時間: 2025-3-23 06:24
Thick-Walled Gallbladder: Differential Diagnosis and Surgical Approach to a Thickened Gallbladderoses a therapeutic as well as a diagnostic challenge. Thick-walled gallbladder can be double-edged sword where morbid procedure could be performed for a benign pathology and vice versa. Following strict protocols and having a stringent clinical judgment may prevent any catastrophe.作者: NUDGE 時間: 2025-3-23 10:58 作者: Graphite 時間: 2025-3-23 15:32
Book 2023atment therapeutics targets for gallbladder cancer patients have been identified and the field is evolving rapidly. . The book is relevant for the clinical researcher, surgeon, scientist and academician..作者: Commonplace 時間: 2025-3-23 19:43 作者: 黃瓜 時間: 2025-3-23 22:57 作者: 粗鄙的人 時間: 2025-3-24 04:17 作者: GROVE 時間: 2025-3-24 09:02 作者: 健忘癥 時間: 2025-3-24 10:43
The Analysis of Business ProcessesERK, PI3K/AKT/mTOR, ErbB1, TP53, HER2, KRAS, VEGF, HIF1, and PTCH1/SMO/GLI1 in gallbladder cancer pathogenesis. Developing an effective targeted therapy by inhibiting these signaling molecules has potential to elevate the treatment efficacy of gallbladder cancer.作者: ETCH 時間: 2025-3-24 18:10
Gallbladder Cancer: Current Treatment Options and Therapeuticsches (such as miRNA/siRNA) which may enhance sensitivity of tumor cells to chemotherapeutic drugs. In addition, noncoding RNAs including miRNAs and lncRNAs have been considered as novel therapeutic measures in controlling progression of gallbladder carcinoma.作者: Externalize 時間: 2025-3-24 23:05
A Look at Emerging Therapeutic Targets for Gallbladder Cancer: A Multi-Omics Approachns are dysregulated in GBC. Importantly, we highlight their potential use as therapeutic biomarkers due to their functions in GBC progression. Lastly, we review emerging strategies such as immunotherapy and their potential of improving patient survival.作者: 使人入神 時間: 2025-3-25 01:52
Targeted Treatment of Gallbladder Cancera is an early sign of potential of targeted therapy in biliary tract cancers which is enriched in targetable molecular pathways in two-third of the cases. We reviewed the literature and highlighted the emerging new and effective treatment strategies for this otherwise aggressive and fatal disease.作者: 挫敗 時間: 2025-3-25 05:55
Targeted Therapy: Molecular Pathology and Targets of Gallbladder Canceres to occlude the atypical signaling pathway in gallbladder cancer. We also mention the clinical trials associated with combination targeted therapy for gallbladder cancer that may offer favorable therapeutic.作者: maintenance 時間: 2025-3-25 08:03
Targeted Therapies in Gallbladder Cancer: Current Status and Future PerspectivesERK, PI3K/AKT/mTOR, ErbB1, TP53, HER2, KRAS, VEGF, HIF1, and PTCH1/SMO/GLI1 in gallbladder cancer pathogenesis. Developing an effective targeted therapy by inhibiting these signaling molecules has potential to elevate the treatment efficacy of gallbladder cancer.作者: 不適當(dāng) 時間: 2025-3-25 15:37 作者: 公社 時間: 2025-3-25 17:16
Phase II: There is no Alternative!,trials comparing adjuvant chemotherapy versus adjuvant chemoradiation (CRT), the best treatment strategy for high-risk patients is still not established. This chapter summarizes the adjuvant treatment modalities and the evidence supporting the use of adjuvant therapy in GBC.作者: Monolithic 時間: 2025-3-25 20:49 作者: GULLY 時間: 2025-3-26 00:25
Conventional Therapy in Gallbladder Cancerhe management of the patients will mainly depend on the level of invasion of the tumor in the gallbladder wall. For advanced stage cases, some other procedures are performed such as lymphadenectomy, pancreaticoduodenectomy, palliative, chemotherapy, and radiotherapy.作者: 平常 時間: 2025-3-26 05:50 作者: peak-flow 時間: 2025-3-26 08:45 作者: 憲法沒有 時間: 2025-3-26 13:42
Incidental Gallbladder Cancer: The Role of Routine Versus Selective Histopathological Examination ofallbladder, there is an ongoing debate as to whether such a practice should be performed routinely or on a selective basis. This chapter reviews data addressing both strategies. We also report our personal experience on the subject and conclude by providing an evidence-based approach to examining gallbladder specimens.作者: 擦試不掉 時間: 2025-3-26 18:29 作者: ovation 時間: 2025-3-27 00:42
Book 2023developing innovative strategies that may enhance the benefit of conventional chemotherapy. .The book focuses on identifying candidate molecules and the overall status of the targeted therapies available for gallbladder cancer, as there is an urgent need to discover new molecular targets that can gu作者: 連接 時間: 2025-3-27 03:51
978-981-19-6444-2The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapor作者: monologue 時間: 2025-3-27 06:37 作者: Cloudburst 時間: 2025-3-27 12:01
Agency Theory and Executive Payn early stage and complete (R0) resection is achieved. This chapter provides an overview of the current state of surgical management of GBC patients and is structured according to the patient’s presentation. First, epidemiology, risk factors, and staging are discussed, followed by an overview of the作者: abstemious 時間: 2025-3-27 16:11 作者: 豎琴 時間: 2025-3-27 21:32
Agency and Action in Colonial Africa of effective systemic therapy. Surgical extirpation with negative margins remains the only chance for cure in patients with gallbladder cancer. Despite the best attempts at curative resection, a majority of patients with GBC usually recur. Therefore, effective adjuvant therapies are needed to decre作者: 翻布尋找 時間: 2025-3-28 00:40
Planning for War: London and the Localities,ctice there is no agreement on how to approach the assessment of gallbladder specimens. Although there are guidelines on the best way to examine the gallbladder, there is an ongoing debate as to whether such a practice should be performed routinely or on a selective basis. This chapter reviews data 作者: 不開心 時間: 2025-3-28 02:29
Biografie- und agencytheoretischer Zugang,being diagnosed at an advanced stage and being incurable. Surgery is the only option to cure the gallbladder cancer for those patients who diagnosed at an early stage, in addition to adjuvant chemotherapy and radiation. In the present chapter, we will discuss the advent of minimally invasive techniq作者: 思想 時間: 2025-3-28 08:01
A Gradualist Metaphysics of Agencyon and absorption. The presence of lithogenic bile along with superadded infection incites stone formation and subsequent clinical symptoms. Prolonged irritation of the gallbladder mucosa due to a large stone causes metaplasia and dysplasia sequence. Thick-walled gallbladder can be present in multip作者: 反感 時間: 2025-3-28 12:28
https://doi.org/10.1007/978-3-322-97791-5ncidental GBC on pathological examination. Most patients are staged with pT2 (50%) or pT1 (33%) of GBC. Patients with GBC confined to the mucosa (T1a or less) had 5-year survival rates of up to 100% after cholecystectomy alone. For cancers invading the muscle layer of the gallbladder wall (T1b or ab作者: Mammal 時間: 2025-3-28 16:55 作者: bizarre 時間: 2025-3-28 18:59 作者: daredevil 時間: 2025-3-29 02:17
https://doi.org/10.1007/978-3-663-09225-4common symptoms present at an advanced stage. Conventional chemotherapy and radiation have not shown much improvement in terms of survival and quality of life. MicroRNA technology is a novel and exciting development in cancer diagnostic and therapeutic and may potentially address shortcomings relate作者: DAFT 時間: 2025-3-29 03:48 作者: moribund 時間: 2025-3-29 10:44
Agenda-Setting zwischen Parlament und Medienrld precluded it from active research for the last two decades. Gemcitabine- and platinum-based combination therapy remained the treatment of choice over these years. Delayed presentations and aggressive biology made this disease largely incurable in early disease state and goal remains palliative i作者: glacial 時間: 2025-3-29 13:02 作者: ticlopidine 時間: 2025-3-29 17:09 作者: 你敢命令 時間: 2025-3-29 19:56
The Analysis of Business Processestage of disease. There is a need for an effective treatment regimen to circumvent the high mortality rate. Current therapeutic approach is the surgical resection followed by chemotherapy and radiotherapy. Recent advancements in high throughput sequencing technology, whole proteome and transcriptome 作者: 我沒有命令 時間: 2025-3-30 03:06
Vijay Kumar Shukla,Manoj Pandey,Ruhi DixitSurgical Management, Adjuvant Chemotherapy and Palliative Chemotherapy in gallbladder cancer.Targeted Therapies in gallbladder cancer.Clinical trials in gallbladder cancer treatment作者: BOLUS 時間: 2025-3-30 07:22
https://doi.org/10.1007/978-981-19-6442-8Gallbladder Cancer; Cholelithiasis; Cholecystectomy; Chemotherapy; Therapeutics作者: 吵鬧 時間: 2025-3-30 08:35 作者: MURKY 時間: 2025-3-30 15:49
